Term Name: EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor
Synonyms: dual oxidase inhibitor, dual oxidase inhibitors, EC 1.6.3.1 inhibitor, EC 1.6.3.1 inhibitors, EC 1.6.3.1. (NAD(P)H oxidase (H2O2-forming)) inhibitor, EC 1.6.3.1. (NAD(P)H oxidase (H2O2-forming)) inhibitors, EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitors, NAD(P)H oxidase (H2O2-forming) (EC 1.6.3.1) inhibitor, NAD(P)H oxidase (H2O2-forming) (EC 1.6.3.1) inhibitors, NAD(P)H oxidase (H2O2-forming) inhibitor, NAD(P)H oxidase (H2O2-forming) inhibitors, NAD(P)H oxidase inhibitor, NAD(P)H oxidase inhibitors, NAD(P)H:oxygen oxidoreductase (H2O2-forming) inhibitor, NAD(P)H:oxygen oxidoreductase (H2O2-forming) inhibitors, NAD(P)H:oxygen oxidoreductase inhibitor, NAD(P)H:oxygen oxidoreductase inhibitors, NADPH oxidase inhibitor, NADPH oxidase inhibitors, p138tox inhibitor, p138tox inhibitors, ThOX inhibitor, ThOX inhibitors, THOX2 inhibitor, THOX2 inhibitors, thyroid NADPH oxidase inhibitor, thyroid NADPH oxidase inhibitors, thyroid oxidase 2 inhibitor, thyroid oxidase 2 inhibitors, thyroid oxidase inhibitor, thyroid oxidase inhibitors
Definition: An EC 1.6.3.* (oxidoreductase acting on NADH or NADPH with oxygen as acceptor) inhibitor that interferes with the action of NAD(P)H oxidase (H2O2-forming), EC 1.6.3.1.
Ontology: ChEBI [CHEBI:50423]  ( EBI )

Relationships
is a type of: EC 1.6.3.* (oxidoreductase acting on NADH or NADPH with oxygen as acceptor) inhibitor
inverse has_role: apocynin dibenziodolium chloride VAS2870